EA
GSK icon

Emerald Acquisition’s GSK GSK Stock Holding History

Emerald Acquisition’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$878K Sell
16,278
-57,413
-78% -$3.15M ﹤0.01% 2196
2016
Q2 		$3.99M Buy
+73,691
New +$3.88M 0.01% 1472

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Emerald Acquisition's GSK Position: Q3 2016 in Review

Emerald Acquisition reduced its GSK (GSK) stake by 78% in Q3 2016, selling an estimated $3.15M and leaving 16,278 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #2196.

Emerald Acquisition first reported a position in GSK in Q2 2016 and has held it in 2 quarters since. The position peaked at $3.99M in Q2 2016. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

  • Emerald Acquisition held 16,278 shares of GSK worth $878K as of Q3 2016.
  • Emerald Acquisition sold 57,413 GSK shares in Q3 2016, an estimated $3.15M.
  • GSK made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2196 holding.
  • Emerald Acquisition first reported a position in GSK in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's GSK position peaked at $3.99M in Q2 2016.
  • 740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.